Vericel (VCEL) EBIT Margin (2011 - 2026)
Vericel (VCEL) recorded EBIT Margin of 0.56% in Q2 2026, up 3.77 percentage points from -3.21% a year earlier and up 12.35 percentage points from the prior quarter.
Powered by 
Analysis
Vericel (VCEL) EBIT Margin (2011 - 2026) Analysis & Trends
On a TTM basis, Vericel's EBIT Margin came in at 5.95% as of Jun 30, 2026, up 5.47 percentage points year-over-year; for FY2025, it was 4.00%, up 2.09 percentage points from FY2024.
- Annual EBIT Margin has increased for three straight years, with a five-year change of +2.09 percentage points (FY2020 to FY2025).
- Across earlier years, EBIT Margin came in at 1.90% in FY2024 (+5.18 pp), -3.27% in FY2023 (+7.11 pp), -10.38% in FY2022 (-5.35 pp) and -5.03% in FY2021 (-6.94 pp).
- Quarterly EBIT Margin has ranged from -24.52% in Q2 2022 to 24.52% in Q4 2024 over the past five years.
- On a year-over-year basis, EBIT Margin rose in six of the last eight quarters, with an average year-over-year change of +3.95 percentage points.
- Peak year-over-year performance for EBIT Margin in the last five years was a gain of 12.54 percentage points in Q1 2026, against a drop of 25.28 percentage points in Q3 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at -11.79% (Q1 2026), 24.12% (Q4 2025) and 5.11% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 37.40% |
| 10 | Vericel | 2.08 Bn | 1.50 Bn | 56.40 Mn | 0.56% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.56% |
| Mar 31, 2026 | -11.79% |
| Dec 31, 2025 | 24.12% |
| Sep 30, 2025 | 5.11% |
| Jun 30, 2025 | -3.21% |
| Mar 31, 2025 | -24.32% |
| Dec 31, 2024 | 24.52% |
| Sep 30, 2024 | -4.26% |
| Jun 30, 2024 | -11.45% |
| Mar 31, 2024 | -10.66% |
| Dec 31, 2023 | 19.59% |
| Sep 30, 2023 | -11.09% |
| Jun 30, 2023 | -12.98% |
| Mar 31, 2023 | -19.94% |
| Dec 31, 2022 | 11.55% |
| Sep 30, 2022 | -17.61% |
| Jun 30, 2022 | -24.52% |
| Mar 31, 2022 | -20.16% |
| Dec 31, 2021 | 8.70% |
| Sep 30, 2021 | -14.38% |
API Access
Vericel EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=VCEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "VCEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=VCEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();